NFE2L2 and Parkinson disease: Therefore, oxidative stress-related Nrf2 activation or its activators can be therapeutically valuable in the treatment of neurodegenerative diseases, including AD, Parkinson’s disease (PD), and Amyotrophic lateral sclerosis [175].